This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Modafinil: Difference between revisions
Jump to navigation
Jump to search
>Oskykins No edit summary |
>Oskykins No edit summary |
||
| Line 54: | Line 54: | ||
|} | |} | ||
'''Modafinil''' (Provigil, Alertec, Modavigil) is | '''Modafinil''' ('''Provigil, Alertec, Modavigil''') is a wakefulness promoting agent (eugeroic) used to enhance cognition, reduce fatigue, and increase alertness. It is approved by the United States' Food and Drug Administration for treatment of obstructive sleep apnea, shift work sleep disorder, and narcolepsy. <ref>Provigal (Manufacturer's Website) | http://www.provigil.com/</ref> | ||
==Chemistry== | ==Chemistry== | ||
| Line 66: | Line 67: | ||
===Physical Effects=== | ===Physical Effects=== | ||
*'''[[Physical effects: Dehydration|Dehydration]]''' | |||
===Cognitive Effects=== | ===Cognitive Effects=== | ||
*'''[[Cognitive effects: Increased focus|Increased Focus]]''' | |||
==Toxicity and Harm Potential== | ==Toxicity and Harm Potential== | ||
| Line 76: | Line 82: | ||
==Legal Issues== | ==Legal Issues== | ||
*In the United States, Modafinil is a Schedule IV controlled substance. It is illegal to buy, sell, or possess the drug without a prescription or DEA license. <ref>Placement of Modafinil Into Schedule IV - U.S. Department of Justice | http://www.deadiversion.usdoj.gov/fed_regs/rules/1999/fr0127.htm</ref> | |||
*Modafinil is listed as a Schedule F prescription drug in Canada, meaning it can be prescribed for human and veterinary use. <ref>National Association of Pharmacy Regulatory Authorities - Regulations Amending the Food and Drug Regulations (1184 — Modafinil) | http://napra.ca/Content_Files/Files/FDR-Project1184-Modafinil-Oct122006.pdf</ref> | |||
* | |||
===See Also=== | ===See Also=== | ||
[[Nootropics]] | |||
===References=== | ===References=== | ||
Revision as of 08:36, 10 March 2014
| Modafinil | |
|---|---|
 Modafinil's 3D molecular structure. | |
| Dosage (oral) | |
| Threshold | 0.5 - 1mg |
| Light | 1 - 1.5mg |
| Common | 1.5 - 2.5mg |
| Strong | 2.5 - 5mg |
| Heavy | 5+mg |
| Dosage (insufflated) | |
| Threshold | 0mg |
| Light | 0 - 0mg |
| Common | 0 - 0mg |
| Strong | 0 - 0mg |
| Heavy | 0 - 0mg |
| Duration (oral) | |
| Onset | 20 - 60 minutes |
| Come up | 20 - 90 minutes |
| Peak | 5 - 10 hours |
| Come down | 1 - 3 hours |
| After effects | 2 - 8 hours |
| Duration (insufflated) | |
| Onset | 0 - 0 minutes |
| Come up | 0 - 0 minutes |
| Peak | 0 - 0 hours |
| Come down | 0 - 0 hours |
| After effects | 0 - 0 hours |
Modafinil (Provigil, Alertec, Modavigil) is a wakefulness promoting agent (eugeroic) used to enhance cognition, reduce fatigue, and increase alertness. It is approved by the United States' Food and Drug Administration for treatment of obstructive sleep apnea, shift work sleep disorder, and narcolepsy. [1]
Chemistry
Pharmacology
Subjective effects
wakefulness, stimulation, motivation, focus, improved memory recall, dehydration, appetite suppression
Physical Effects
Cognitive Effects
Toxicity and Harm Potential
Lethal Dosage
Tolerance and Addiction Potential
Legal Issues
- In the United States, Modafinil is a Schedule IV controlled substance. It is illegal to buy, sell, or possess the drug without a prescription or DEA license. [2]
- Modafinil is listed as a Schedule F prescription drug in Canada, meaning it can be prescribed for human and veterinary use. [3]
See Also
References
- ↑ Provigal (Manufacturer's Website) | http://www.provigil.com/
- ↑ Placement of Modafinil Into Schedule IV - U.S. Department of Justice | http://www.deadiversion.usdoj.gov/fed_regs/rules/1999/fr0127.htm
- ↑ National Association of Pharmacy Regulatory Authorities - Regulations Amending the Food and Drug Regulations (1184 — Modafinil) | http://napra.ca/Content_Files/Files/FDR-Project1184-Modafinil-Oct122006.pdf